Podcast
Questions and Answers
The liver contributes to both the pre-systemic and the systemic ______ of many drugs.
The liver contributes to both the pre-systemic and the systemic ______ of many drugs.
elimination
Intestinal mucosa cells contribute to the ______ elimination of a number of drugs.
Intestinal mucosa cells contribute to the ______ elimination of a number of drugs.
pre-systemic
Phase I reactions include oxidative, reductive, and ______ reactions.
Phase I reactions include oxidative, reductive, and ______ reactions.
hydrolytic
Phase II reactions involve covalent attachment of small polar endogenous molecules in a process also known as a ______ reaction.
Phase II reactions involve covalent attachment of small polar endogenous molecules in a process also known as a ______ reaction.
The majority of phase II reactions are catalysed by ______.
The majority of phase II reactions are catalysed by ______.
The enterohepatic cycle involves the reabsorption of some drugs farther down the ______ tract.
The enterohepatic cycle involves the reabsorption of some drugs farther down the ______ tract.
Some drugs are actively ______ into the renal tubule.
Some drugs are actively ______ into the renal tubule.
Cytochrome P450 is a common ______ enzyme system involved in phase I reactions.
Cytochrome P450 is a common ______ enzyme system involved in phase I reactions.
Unlike phase II reactions, phase I reactions are non-______ and result in the production of less active metabolites
Unlike phase II reactions, phase I reactions are non-______ and result in the production of less active metabolites
Azo reduction and hydrolytic reactions in the colon are observed in drug biotransformation by ______.
Azo reduction and hydrolytic reactions in the colon are observed in drug biotransformation by ______.
The tendency for acids to accumulate in basic fluid compartments, and bases to accumulate in acidic compartments is known as ______ partition.
The tendency for acids to accumulate in basic fluid compartments, and bases to accumulate in acidic compartments is known as ______ partition.
Drugs are easily distributed in highly-perfused organs like the liver, heart and kidney, and distributed in small quantities in less ______ tissues like muscle, fat and peripheral organs.
Drugs are easily distributed in highly-perfused organs like the liver, heart and kidney, and distributed in small quantities in less ______ tissues like muscle, fat and peripheral organs.
The process where a drug is metabolized in the liver before reaching systemic circulation is known as '______' metabolism.
The process where a drug is metabolized in the liver before reaching systemic circulation is known as '______' metabolism.
The volume of distribution (VD) describes the relationship that exists between ______ of a drug and the amount of drug in the body.
The volume of distribution (VD) describes the relationship that exists between ______ of a drug and the amount of drug in the body.
A higher VD indicates a greater amount of ______ distribution.
A higher VD indicates a greater amount of ______ distribution.
Bioavailability is defined as the percentage of administered drug that reaches the ______ circulation.
Bioavailability is defined as the percentage of administered drug that reaches the ______ circulation.
The main factors that affect volume of distribution include an organism's physical volume, the removal or excretion rate of the drug, and the degree to which a drug binds with plasma proteins and / or ______.
The main factors that affect volume of distribution include an organism's physical volume, the removal or excretion rate of the drug, and the degree to which a drug binds with plasma proteins and / or ______.
Once in the bloodstream, a portion of the drug exists as free drug dissolved in ______ water, some will be reversibly taken up by red cells, and some will be reversibly bound to plasma proteins.
Once in the bloodstream, a portion of the drug exists as free drug dissolved in ______ water, some will be reversibly taken up by red cells, and some will be reversibly bound to plasma proteins.
[Blank] means chemical alteration of chemicals such as nutrients, amino acids, toxins, and drugs in the body.
[Blank] means chemical alteration of chemicals such as nutrients, amino acids, toxins, and drugs in the body.
For many drugs, the bound forms can account for 95-98% of the total amount of drugs in ______.
For many drugs, the bound forms can account for 95-98% of the total amount of drugs in ______.
The body typically deals with a foreign compound by making it more ______, to increase the rate of its excretion through the urine.
The body typically deals with a foreign compound by making it more ______, to increase the rate of its excretion through the urine.
It is the ______ drug which traverses cell membranes and produces the effect.
It is the ______ drug which traverses cell membranes and produces the effect.
Protein-bound drug can act as a reservoir which releases drug ______, and thus prolongs its action.
Protein-bound drug can act as a reservoir which releases drug ______, and thus prolongs its action.
Drugs can undergo one of four potential biotransformation processes: active drug to inactive metabolite, active drug to active metabolite, inactive drug to active metabolite, and active drug to ______ metabolite.
Drugs can undergo one of four potential biotransformation processes: active drug to inactive metabolite, active drug to active metabolite, inactive drug to active metabolite, and active drug to ______ metabolite.
The distribution of a drug between tissues is dependent on vascular permeability, regional blood flow, cardiac output, perfusion rate of the tissue, the ability of the drug to bind tissue and plasma proteins, lipid solubility and ______.
The distribution of a drug between tissues is dependent on vascular permeability, regional blood flow, cardiac output, perfusion rate of the tissue, the ability of the drug to bind tissue and plasma proteins, lipid solubility and ______.
The unbound or free drug usually follows its ______ gradient in entering into peripheral tissues.
The unbound or free drug usually follows its ______ gradient in entering into peripheral tissues.
The volume of ______ determines the equilibrium concentration of drug after a specified dose.
The volume of ______ determines the equilibrium concentration of drug after a specified dose.
Occasionally, we administer a parent drug which is inactive -- a ______ -- and only the metabolite has activity.
Occasionally, we administer a parent drug which is inactive -- a ______ -- and only the metabolite has activity.
Once a drug enters into the systemic circulation, it is distributed into ______ and intracellular fluids.
Once a drug enters into the systemic circulation, it is distributed into ______ and intracellular fluids.
"______" binding sites of drugs act as further reservoirs for the drug, influencing its duration of action and availability for therapeutic effects.
"______" binding sites of drugs act as further reservoirs for the drug, influencing its duration of action and availability for therapeutic effects.
Flashcards
First-Pass Metabolism
First-Pass Metabolism
Metabolism of a drug before it reaches systemic circulation, reducing bioavailability after oral administration.
Bioavailability
Bioavailability
The percentage of administered drug that reaches the systemic circulation.
Free Drug
Free Drug
The portion of drug dissolved in plasma water that can traverse cell membranes and produce effects.
Protein-Bound Drug
Protein-Bound Drug
Signup and view all the flashcards
Drug Distribution
Drug Distribution
Signup and view all the flashcards
Volume of Distribution
Volume of Distribution
Signup and view all the flashcards
Interstitial Fluid
Interstitial Fluid
Signup and view all the flashcards
Intracellular fluid
Intracellular fluid
Signup and view all the flashcards
Systemic Circulation
Systemic Circulation
Signup and view all the flashcards
Drug Metabolism
Drug Metabolism
Signup and view all the flashcards
Drug Biotransformation
Drug Biotransformation
Signup and view all the flashcards
Sites of Drug Biotransformation
Sites of Drug Biotransformation
Signup and view all the flashcards
Phase I Reactions
Phase I Reactions
Signup and view all the flashcards
Cytochrome P450
Cytochrome P450
Signup and view all the flashcards
Phase II Reactions
Phase II Reactions
Signup and view all the flashcards
Transferases
Transferases
Signup and view all the flashcards
Drug Excretion
Drug Excretion
Signup and view all the flashcards
Primary Organ for Drug Metabolism
Primary Organ for Drug Metabolism
Signup and view all the flashcards
Enterohepatic Cycle
Enterohepatic Cycle
Signup and view all the flashcards
Primary Organ for Drug Excretion
Primary Organ for Drug Excretion
Signup and view all the flashcards
Vascular Permeability
Vascular Permeability
Signup and view all the flashcards
Regional Blood Flow
Regional Blood Flow
Signup and view all the flashcards
Cardiac Output & Perfusion
Cardiac Output & Perfusion
Signup and view all the flashcards
Drug-Protein Binding
Drug-Protein Binding
Signup and view all the flashcards
Lipid Solubility
Lipid Solubility
Signup and view all the flashcards
pH Partitioning
pH Partitioning
Signup and view all the flashcards
Volume of Distribution (Vd)
Volume of Distribution (Vd)
Signup and view all the flashcards
Biotransformation
Biotransformation
Signup and view all the flashcards
Pro-drug
Pro-drug
Signup and view all the flashcards
Study Notes
- When a drug is injected directly into the bloodstream, 100% of it is available for distribution to tissues.
First-Pass Metabolism
- Oral drug administration requires absorption via the portal circulation.
- The "first-pass" effect involves the drug passing through the liver before reaching systemic circulation.
- During first-pass metabolism, the drug concentration is reduced due to metabolism in the liver.
- First-pass metabolism reduces the drug amount available for distribution in the tissues to less than 100%.
- Bioavailability is the percentage of administered drug that reaches the systemic circulation.
Drug Distribution
- Once in the bloodstream, a drug exists as a free drug (dissolved in plasma water) or bound to red blood cells and/or plasma proteins.
- Most drugs (95-98%) are bound in circulation, but the free drug is responsible for traversing cell membranes and producing effects.
- Protein-bound drugs act as a reservoir that slowly releases the drug, prolonging its action.
- Unbound drugs follow the concentration gradient to enter peripheral tissues.
- Tissues may contain the target site (receptor) for drug action, or be unaffected by the drug.
- Non-specific binding sites can also act as drug reservoirs.
- The volume of distribution determines the equilibrium concentration of a drug after a specific dose.
- Tissue-bound drugs eventually re-enter circulation.
- Drugs distribute into interstitial and intracellular fluids after entering systemic circulation.
- Distribution of a drug between tissues depends on vascular permeability, regional blood flow, cardiac output, tissue perfusion rate, drug binding to tissues/plasma proteins, lipid solubility, and pH partition.
- Acidic drugs accumulate in basic fluids, and basic drugs accumulate in acidic fluids due to electric charge.
- Highly-perfused organs (liver, heart, kidney) receive drugs easily, unlike less perfused tissues (muscle, fat).
- Drugs can move between plasma and tissue until equilibrium is established for the unbound amount.
Volume of Distribution
- Volume of distribution (VD) describes the relationship between drug concentration and amount in the body.
- VD shows the distribution of a drug between plasma and the rest of the body after oral or parenteral administration.
- A higher VD means greater drug distribution into tissues.
- Factors affecting VD include physical volume, drug removal/excretion rate, and drug binding with plasma proteins/tissues.
Biotransformation/Metabolism
- Biotransformation is the chemical alteration of chemicals like nutrients, amino acids, toxins, and drugs in the body.
- The body increases water solubility to excrete foreign compounds through urine.
- Drugs can undergo biotransformation:
- Active drug to inactive metabolite
- Active drug to active metabolite
- Inactive drug to active metabolite
- Active drug to toxic metabolite
- Occasionally, a parent drug is administered in an inactive form (pro-drug), and only the metabolite has activity.
- Drug biotransformation occurs in the liver which contributes to pre-systemic and systemic elimination, intestinal mucosa cells which contribute to pre-systemic elimination, and renal tubular cells and colon which is caused by bacteria.
- Drug biotransformation pathways are categorized into phase I and phase II reactions:
- Phase I reactions include oxidative, reductive, and hydrolytic reactions where a polar group is introduced/unmasked, making the drug more water-soluble for excretion.
- Phase I reactions are non-synthetic and result in less active metabolites.
- Cytochrome P450 generates the majority of phase I metabolites.
- Phase II reactions involve covalent attachment of small polar endogenous molecules (glucuronic acid, sulfate, glycine) to form water-soluble compounds, known as conjugation reactions.
- Transferases catalyze the reaction.
- The final compounds have a larger molecular weight.
Drug Excretion
- The liver metabolizes most drugs into inactive or less active compounds for excretion.
- Metabolites and some parent compounds may be excreted in the bile and pass out in the faeces.
- Alternatively, some drugs are reabsorbed through the GI tract.
- Parent drug and metabolites in the bloodstream are filtered by the kidney, with a portion undergoing reabsorption, and the remainder excreted in the urine.
- Some drugs are actively secreted into the renal tubule.
- Lungs eliminate alcohol and anesthetic gases.
- Small amounts of drugs are eliminated in sweat, tears, and breast milk.
Studying That Suits You
Use AI to generate personalized quizzes and flashcards to suit your learning preferences.
Related Documents
Description
When a drug is injected directly into the bloodstream, 100% of it is available. Oral drug administration requires absorption. First-pass metabolism reduces the drug amount available for distribution. Most drugs are bound in circulation.